Literature DB >> 29016781

Effectiveness, safety, and long-term outcomes of non-powered mechanical sheaths for transvenous lead extraction.

Andrzej Kutarski1, Marek Czajkowski2, Radoslaw Pietura3, Bogdan Obszanski4, Anna Polewczyk5,6, Wojciech Jachec7, Maciej Polewczyk8, Krzysztof Mlynarczyk9, Marcin Grabowski10, Grzegorz Opolski10.   

Abstract

Aims: To analyse the effectiveness, safety and long-term outcomes of conventional non-powered mechanical systems for transvenous lead extraction (TLE) performed by experienced first operators. Outcomes were assessed according to lead location and type of operating room in which the procedure was performed. Methods and results: Data from 2049 patients (mean age: 65 years), with infectious (40%) or non-infectious (60%) indications, were analysed over a mean of 3.37 (±2.29) years. A total of 3426 leads were extracted; and, overall, 95% full procedural, 4% partial procedural, and 98% clinical success were demonstrated. Within the patient cohort, 1.8% (37/2049) experienced major complications, with cardiac tamponade being predominant (30/37). Cardiac tamponade was identified as the main cause of mortality, as well as the cause of all procedure-related deaths (6/2049; 0.3%). Cardiac tamponade occurred in 1.8% of atrial and 0.3% of right ventricular lead extractions, with fatal tamponade reported in 9% of atrial, 40% of ventricular, and 67% of coronary sinus lead extractions. No association between lead location and cardiac tamponade-related mortality was observed; however, lead location did affect the success of pericardiocentesis. The cardiac tamponade-related mortality rate was 37% when TLE was performed in an electrophysiology laboratory. No deaths were reported when the procedure was performed in a cardiac surgery or hybrid operating room. Long-term survival was improved when TLE was performed due to non-infectious indications, rather than pocket infection or lead-related endocarditis (P < 0.001).
Conclusion: Using conventional non-powered mechanical sheaths, TLE was effective even in patients at high risk of complications.

Entities:  

Mesh:

Year:  2018        PMID: 29016781     DOI: 10.1093/europace/eux218

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  4 in total

1.  Safety and Effectiveness of Transvenous Lead Extraction in Patients with Infected Cardiac Resynchronization Therapy Devices; Is It More Risky than Extraction of Other Systems?

Authors:  Paweł Stefańczyk; Dorota Nowosielecka; Anna Polewczyk; Łukasz Tułecki; Konrad Tomków; Wojciech Jacheć; Ewa Lewicka; Andrzej Tomaszewski; Andrzej Kutarski
Journal:  Int J Environ Res Public Health       Date:  2022-05-10       Impact factor: 4.614

2.  Prognostic Value of Preoperative Echocardiographic Findings in Patients Undergoing Transvenous Lead Extraction.

Authors:  Dorota Nowosielecka; Wojciech Jacheć; Anna Polewczyk; Łukasz Tułecki; Andrzej Kleinrok; Andrzej Kutarski
Journal:  Int J Environ Res Public Health       Date:  2021-02-14       Impact factor: 3.390

3.  Tricuspid Valve Damage Related to Transvenous Lead Extraction.

Authors:  Anna Polewczyk; Wojciech Jacheć; Dorota Nowosielecka; Andrzej Tomaszewski; Wojciech Brzozowski; Dorota Szczęśniak-Stańczyk; Krzysztof Duda; Andrzej Kutarski
Journal:  Int J Environ Res Public Health       Date:  2022-09-27       Impact factor: 4.614

4.  Transvenous Lead Extraction without Procedure-Related Deaths in 1000 Consecutive Patients: A Single-Center Experience.

Authors:  Paweł Stefańczyk; Dorota Nowosielecka; Łukasz Tułecki; Konrad Tomków; Anna Polewczyk; Wojciech Jacheć; Andrzej Kleinrok; Wojciech Borzęcki; Andrzej Kutarski
Journal:  Vasc Health Risk Manag       Date:  2021-08-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.